Wells Fargo & Company Elanco Animal Health Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Wells Fargo & Company holds 284,444 shares of ELAN stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

284,444

Previous 231,453 22.89%

Holding current value

$3.34 Million

Previous $3.34 Million 25.04%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$11.85 - $15.47 $627,943 - $819,770	52,991 Added 22.89%	284,444 $4.18 Million
Q2 2024 Aug 13, 2024	BUY	$12.93 - $18.45 $624,105 - $890,544	48,268 Added 26.35%	231,453 $3.34 Million
Q1 2024 May 10, 2024	BUY	$14.37 - $16.46 $578,478 - $662,613	40,256 Added 28.17%	183,185 $2.98 Million
Q4 2023 Feb 09, 2024	BUY	$8.6 - $14.94 $45,382 - $78,838	5,277 Added 3.83%	142,929 $2.13 Million
Q3 2023 Nov 13, 2023	SELL	$9.81 - $12.62 $941,730 - $1.21 Million	-95,997 Reduced 41.09%	137,652 $1.55 Million
Q2 2023 Aug 15, 2023	SELL	$8.08 - $10.37 $2,205 - $2,831	-273 Reduced 0.12%	233,649 $2.35 Million
Q1 2023 May 12, 2023	BUY	$8.79 - $14.58 $109,593 - $181,783	12,468 Added 5.63%	233,922 $2.2 Million
Q4 2022 Feb 13, 2023	SELL	$11.49 - $13.65 $1.64 Million - $1.95 Million	-143,023 Reduced 39.24%	221,454 $2.71 Million
Q3 2022 Nov 14, 2022	SELL	$12.41 - $32.42 $20.8 Million - $54.4 Million	-1,677,285 Reduced 82.15%	364,477 $4.52 Million
Q2 2022 Aug 12, 2022	SELL	$19.63 - $26.62 $1.75 Million - $2.37 Million	-88,928 Reduced 4.17%	2,041,762 $40.1 Million
Q1 2022 May 16, 2022	BUY	$24.65 - $29.0 $19.3 Million - $22.7 Million	784,367 Added 58.26%	2,130,690 $55.6 Million
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $25.3 Million - $31.1 Million	-912,780 Reduced 40.4%	1,346,323 $38.2 Million
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $21.4 Million - $27 Million	733,985 Added 48.13%	2,259,103 $72 Million
Q2 2021 Aug 16, 2021	SELL	$28.76 - $35.98 $20.3 Million - $25.4 Million	-706,945 Reduced 31.67%	1,525,118 $52.9 Million
Q1 2021 May 13, 2021	SELL	$27.85 - $34.49 $25 Million - $31 Million	-897,767 Reduced 28.68%	2,232,063 $65.7 Million
Q4 2020 Feb 09, 2021	BUY	$27.53 - $33.79 $40.6 Million - $49.9 Million	1,475,788 Added 89.22%	3,129,830 $96 Million
Q3 2020 Nov 05, 2020	BUY	$21.1 - $29.13 $3.79 Million - $5.23 Million	179,611 Added 12.18%	1,654,042 $46.2 Million
Q2 2020 Aug 13, 2020	SELL	$18.94 - $24.93 $47.6 Million - $62.7 Million	-2,515,212 Reduced 63.04%	1,474,431 $31.6 Million
Q1 2020 May 14, 2020	BUY	$16.68 - $32.25 $66.5 Million - $129 Million	3,989,643 New	3,989,643 $89.3 Million

Others Institutions Holding ELAN

# of Institutions

438

Shares Held

473M

Call Options Held

4.62M

Put Options Held

753K

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.56B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Elanco Animal Health Inc Transaction History